Skip to Content
Merck

Skip To

CR0003L200

Mobius® 3 L Bioreactor

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Pack SizeSKUAvailabilityPrice
2 ea

Available to ship TODAYfromMerck (C/O Rhenus Logistics)

€1,200.00

About This Item

eCl@ss:
32031690
UNSPSC Code:
23151806

€1,200.00


Available to ship TODAYDetails


Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

General description

The Mobius® 3 L bioreactor is a single-use, stirred tank bioreactor for bench-scale cell culture in fed-batch or perfusion mode. Its rigid design includes a semi-hemispherical shaped polycarbonate vessel, a multi-port high-density polyethylene (HDPE) headplate, a scoping marine impeller, both open pipe and sintered spargers, weldable C-Flex® tubing, and all necessary gas inlet and outlet filters. It contains ports below the minimum working volume level including one luer actuated sample port, one liquid inlet/outlet port, two liquid addition lines, sparging lines and a harvest line. All gas and liquid addition ports located below the minimum working volume incorporate check valves to ensure uni-directional flow of gas or liquid. The Mobius® 3 L Bioreactor is pre-assembled, gamma irradiated and shipped ready to use.

Legal Information

C-Flex is a registered trademark of Saint-Gobain Performance Plastics Corp.
MOBIUS is a registered trademark of Merck KGaA, Darmstadt, Germany




Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Articles

High cell density cryopreservation (HCDC) is a closed processing alternative to the traditional seed train expansion process. Learn more about the benefits of HCDC.

A custom-designed cost model is used to explore the economics of vaccine manufacturing across several different modalities including mRNA. The model enables greater process understanding, simulates bottlenecks, and helps to optimize production efficiency.

Influenza vaccines are commonly made using egg-based and cell-based manufacturing strategies. Find step-by-step information on the manufacturing process for each method.

View All Articles

Related Content

Mobius® iFlex Bioreactor family offers single-use bioreactors for mammalian cell culturing from development to production.

This technical article breaks down the adenovirus vaccine manufacturing process and provides a case study on developing an accelerated and cost-effective single-use adenoviral vector vaccine.





Questions

Reviews

No rating value

Active Filters